COVID-19 Vaccine Hesitancy among French People Living with HIV
People living with HIV are a high-risk population concerning the coronavirus 19 (COVID-19) infection, with a poorer prognosis. It is important to achieve high COVID-19 vaccination coverage rates in this group as soon as possible. This project used self-reporting to assess vaccine hesitancy and accep...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/4/302 |
id |
doaj-f2e78ee8110c4a3f80525ee39dc79a7a |
---|---|
record_format |
Article |
spelling |
doaj-f2e78ee8110c4a3f80525ee39dc79a7a2021-03-25T00:00:04ZengMDPI AGVaccines2076-393X2021-03-01930230210.3390/vaccines9040302COVID-19 Vaccine Hesitancy among French People Living with HIVAlexandre Vallée0Erwan Fourn1Catherine Majerholc2Pauline Touche3David Zucman4Department of Clinical Research and Innovation, Foch Hospital, 92150 Suresnes, FranceDepartment of Internal Medicine, Réseau Ville Hôpital Val de Seine, Foch Hospital, 92150 Suresnes, FranceDepartment of Internal Medicine, Réseau Ville Hôpital Val de Seine, Foch Hospital, 92150 Suresnes, FranceDepartment of Clinical Research and Innovation, Foch Hospital, 92150 Suresnes, FranceDepartment of Internal Medicine, Réseau Ville Hôpital Val de Seine, Foch Hospital, 92150 Suresnes, FrancePeople living with HIV are a high-risk population concerning the coronavirus 19 (COVID-19) infection, with a poorer prognosis. It is important to achieve high COVID-19 vaccination coverage rates in this group as soon as possible. This project used self-reporting to assess vaccine hesitancy and acceptance among people living with HIV towards the novel COVID-19 vaccine. Sixty-eight (28.7%) participants among the 237 declared their hesitancy to be vaccinated against COVID-19. Participants who expressed concerns about their health (<i>p</i> < 0.001), the requirement of mandatory COVID-19 vaccination (<i>p</i> = 0.017), and their chronic disease status (<i>p</i> = 0.026) were independently associated with the acceptance of vaccination. Conversely, participants presenting general vaccine refusal (<i>p</i> < 0.001), concerns about the serious side effects of COVID-19 vaccines (<i>p</i> < 0.001), and those already thinking having an immune status to COVID-19 (<i>p</i> = 0.008) were independently associated with COVID-19 vaccine hesitancy. Our results suggest that vaccine strategy would be more successful in France with a communication strategy emphasizing the collective benefits of herd immunity in the population living with HIV and reassuring patients with chronic diseases about the safety of the proposed vaccines.https://www.mdpi.com/2076-393X/9/4/302COVID-19COVID-19 vaccinevaccine hesitancyHIV |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexandre Vallée Erwan Fourn Catherine Majerholc Pauline Touche David Zucman |
spellingShingle |
Alexandre Vallée Erwan Fourn Catherine Majerholc Pauline Touche David Zucman COVID-19 Vaccine Hesitancy among French People Living with HIV Vaccines COVID-19 COVID-19 vaccine vaccine hesitancy HIV |
author_facet |
Alexandre Vallée Erwan Fourn Catherine Majerholc Pauline Touche David Zucman |
author_sort |
Alexandre Vallée |
title |
COVID-19 Vaccine Hesitancy among French People Living with HIV |
title_short |
COVID-19 Vaccine Hesitancy among French People Living with HIV |
title_full |
COVID-19 Vaccine Hesitancy among French People Living with HIV |
title_fullStr |
COVID-19 Vaccine Hesitancy among French People Living with HIV |
title_full_unstemmed |
COVID-19 Vaccine Hesitancy among French People Living with HIV |
title_sort |
covid-19 vaccine hesitancy among french people living with hiv |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2021-03-01 |
description |
People living with HIV are a high-risk population concerning the coronavirus 19 (COVID-19) infection, with a poorer prognosis. It is important to achieve high COVID-19 vaccination coverage rates in this group as soon as possible. This project used self-reporting to assess vaccine hesitancy and acceptance among people living with HIV towards the novel COVID-19 vaccine. Sixty-eight (28.7%) participants among the 237 declared their hesitancy to be vaccinated against COVID-19. Participants who expressed concerns about their health (<i>p</i> < 0.001), the requirement of mandatory COVID-19 vaccination (<i>p</i> = 0.017), and their chronic disease status (<i>p</i> = 0.026) were independently associated with the acceptance of vaccination. Conversely, participants presenting general vaccine refusal (<i>p</i> < 0.001), concerns about the serious side effects of COVID-19 vaccines (<i>p</i> < 0.001), and those already thinking having an immune status to COVID-19 (<i>p</i> = 0.008) were independently associated with COVID-19 vaccine hesitancy. Our results suggest that vaccine strategy would be more successful in France with a communication strategy emphasizing the collective benefits of herd immunity in the population living with HIV and reassuring patients with chronic diseases about the safety of the proposed vaccines. |
topic |
COVID-19 COVID-19 vaccine vaccine hesitancy HIV |
url |
https://www.mdpi.com/2076-393X/9/4/302 |
work_keys_str_mv |
AT alexandrevallee covid19vaccinehesitancyamongfrenchpeoplelivingwithhiv AT erwanfourn covid19vaccinehesitancyamongfrenchpeoplelivingwithhiv AT catherinemajerholc covid19vaccinehesitancyamongfrenchpeoplelivingwithhiv AT paulinetouche covid19vaccinehesitancyamongfrenchpeoplelivingwithhiv AT davidzucman covid19vaccinehesitancyamongfrenchpeoplelivingwithhiv |
_version_ |
1724204369881071616 |